Screening, diagnosis, surgery and treatment have all been affected. In an area of medicine which is especially time-sensitive, this knock-on effect can be devastating. For some, the effect is on their quality of life; for others, it will mean the cancer has spread, and others will have a lower chance of survival.
Cancer Research UK and others have highlighted this issue and the need to improve patient care.
Their research found that for every week cancer screening is paused, 7,000 people are not being referred for further tests and 380 cancers are not being diagnosed through screening programmes.
Other research has tried to estimate the number of extra cancer deaths that could be caused by service disruption during the pandemic. The numbers of avoidable deaths range from 3,300 to 60,000.
Cancer Research UK’s Chief Clinician, Professor Charles Swanton, put it simply: “Patients shouldn’t need to wait for this to be over before getting the treatment they need.” He said it is possible to create a safe environment for both staff and cancer patients.
As a clinical negligence team with expertise in dealing with cases involving cancer, we have first-hand experience of how difficult it is to treat at any time, let alone during a pandemic. The earlier a diagnosis is made and appropriate treatment is given, the better the chances of recovery and survival. Thankfully the NHS has made significant advances in its screening and treatment of cancer in recent years which undoubtedly has saved lives, but the concerns highlighted by Cancer Research UK at this particular time, relating to potential delays in diagnosis and treatment, should not be underestimated in respect of the impact on positive outcomes.
We are only too aware that treatment for cancer will depend on its type, where it is in the body and how advanced it is at the time of diagnosis. The main forms of treatment are surgery, radiotherapy, chemotherapy and hormone treatment for some types. Our previous cases show that if these treatments are delayed this can result in the spread of the cancer to other parts of the body, requiring more invasive and complex treatment, which ultimately may reduce the patient’s chance of long-term survival or cure.
If you have any questions relating to this e-briefing or concerns about cancer care you or a relative have received, please contact Ann Houghton who will be happy to speak to you on an initial free, no-obligation basis.
We now know what the short-term holds for public procurement at the end of the Brexit transitional period.
Daniel Brewer from Resonance talks about his journey into investing in enterprise with a social purpose, and discusses what the landscape looks like for social businesses post Covid-19.
On 1 December 2020 the Court of Appeal handed down judgment in Pimlett v Curo Places Limited EWCA Civ 1621 where prior judgments in the First-tier Tribunal and the Upper Tribunal were overturned.
For part 3 in this series of short podcasts, Chris Lloyd-Smith interviews senior associate Madhur Sharma on how she has been coping during these unprecedented times.
On 26 November 2020 further changes to the 'Building Regulations: Fire safety - Approved Document B' will take effect.
Last week, the NHF published its final version of its new Code of Governance and made some important changes from the previous draft that will impact on those housing associations looking to adopt it.
As the end of 2020 beckons, we take a look at what progress the Sterling market has made in its preparations for the end of the London Interbank Offered Rate (LIBOR) on 31 December 2021.
Finally, there is a glimmer of hope that perhaps the Covid-19 pandemic could be reaching its end.
For part 2 in this series of short podcasts, Chris Lloyd-Smith interviews senior associate Lisa Whitehouse on how she has been coping during these unprecedented times.
To receive invitations to our events, as well as information and articles on legal issues and sector developments that are of interest to you, please sign up to Newsroom.